[The mechanism of the prevention by ethomersol of disorders in erythrocyte deformability in cerebral ischemia and recirculation].
Plotnikova
T M
TM
Firsov
N N
NN
Baizova
O E
OE
D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use*; D001809:Blood Viscosity / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D004907:Erythrocyte Deformability / Q000187:drug effects*; D005260:Female; D002546:Ischemic Attack, Transient / Q000097:blood / Q000188:drug therapy*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D051381:Rats; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D001562:Benzimidazoles; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; C070941:ethomersol
Mekhanizm preduprezhdeniia étomerzolom narusheniĭ deformiruemosti éritrotsitov pri ishemii mozga i retsirkuliatsii.